Alpha Tau Medical Ltd. (DRTS), a clinical-stage oncology company pioneering alpha-radiation cancer therapy, is accelerating its clinical and regulatory progress in 2025, with several U.S. and international trials underway and new FDA approvals setting the stage for a pivotal year.
Q1, 2025 Financial Performance:
For comments and feedback contact: editorial@rttnews.com
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.